Zymeworks, Inc. (ZYME)
24.33
-0.10
(-0.41%)
USD |
NASDAQ |
May 19, 15:30
Zymeworks Research and Development Expense (Quarterly) : 34.46M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 13.81M |
| Alnylam Pharmaceuticals, Inc. | 364.87M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Vertex Pharmaceuticals, Inc. | 961.60M |
| AbbVie, Inc. | 2.472B |